Abingworth LLP Spruce Biosciences, Inc. Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

A detailed history of Abingworth LLP transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Abingworth LLP holds 1,792,518 shares of SPRB stock, worth $191 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
1,792,518
Previous 1,792,518 -0.0%
Holding current value
$191 Million
Previous $2.47 Million 20.33%
% of portfolio
0.65%
Previous 0.85%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$1.18 - $2.19 $2.12 Million - $3.93 Million
1,792,518 New
1,792,518 $2.47 Million

Others Institutions Holding SPRB

# of Institutions
3
Shares Held
4.85M
Call Options Held
0
Put Options Held
0
View Full List

About SPRUCE BIOSCIENCES, INC.

SPRB Quotes by TradingView
  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $2.51B
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email